#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease


Authors: Z. Merta
Authors‘ workplace: Klinika nemocí plicních a TBC FN Brno
Published in: Kardiol Rev Int Med 2009, 11(4): 178-180
Category: Sympozium

Overview

Pulmonary hypertension (PH) is not a disease as such but rather a haemodynamic consequence of a variety of diseases, both pulmonary and cardiovascular. However, there is a small but important subgroup considered as idiopathic (idiopathic pulmonary arterial hypertension – IPAH). Otherwise – unlike in systemic hypertension – the origin of PH is mostly secondary. Pulmonary hypertension is a syndrome defined by the elevation of the mean pulmonary artery pressure (PAP) to > 25 mmHg at rest, or > 30 mmHg during exercise. Chronic obstructive pulmonary disease (COPD), the prevalence of which increased during the past decade, is a major cause of morbidity and mortality worldwide. One well‑known complication of COPD is PH – a condition that was previously known as ‘cor pulmonale’. Owing to its frequency, COPD is by far the most common cause of PH, far more common than other entities occurring within the latest WHO classification of PH (The Venice Classification, 2003). Although PH is frequently observed in patients with advanced COPD, the prevalence of PH is still unknown. At present, PH is considered a marker of the duration and severity of COPD. Mild to moderate degree of PH is probably the most important characteristic of COPD‑associated PH; this, in turn, provides some opportunities for treatment or improvement.

Keywords:
pulmonary hypertension – chronic obstructive pulmonary disease – pathogenesis and prognosis of PH in COPD


Sources

1. Widimský J. Plicní hypertenze u chronické obstrukční plicní nemoci. Cor Vasa 2009; 51: 462–469.

2. Riedel M. Choroby plicního oběhu. Praha: Galén 2000.

3. Cooper R, Ghali J, Simmons BE et al. Elevated pulmonary artery pressure. An independent predictor of mortality. Chest 1991; 99: 112–120.

4. Al-Hiti H, Melenovský V, Kettner J et al. Plicní hypertenze a chronické srdeční selhání. Cor Vasa 2009; 51: 478–480.

5. Simonneau G, Galiè N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S–12S.

6. Chaouat A, Bugnet AS, Kadaoui N et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 189–194.

7. Weitzenblum E. Chronic cor pulmnale. Heart 2003; 89: 225–230.

8. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patiens with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–946.

9. Scharf SM, Igbal M, Keller C et at. National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166: 314–322.

10. Williams BT, Nicholl JP. Prevalence of hypoxaemic chronic obstructive lung disease with reference to long‑term oxygen therapy. Lancet 1985; 2: 369–372.

11. Chaouat A, Bugnet AS, Kadoui N et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 189–194.

12. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32: 1371–1385.

13. Butler J, Schrijen F, Henriquez A et al. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138: 350–354.

14. Peñaloza D, Sime F, Banchero N et al. Pulmonary hypertension in healthy man born and living at high altidudes. Med Thorac 1962; 19: 449–460.

15. Weitzenblum E, Loiseau A, Hirth C et al. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 1979; 75: 656–662.

16. Weitzenblum E, Sautegeau E, Ehrhardt M et al. Long‑term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 993–999.

17. Weitzenblum E, Hirth C, Duculone A et al. Prognostic value of pulmonary artery pressure in chronic obstructive lung disease. Thorax 1981; 36: 752–758.

Labels
Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#